Literature DB >> 31352975

A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia.

Bianca Covella1, Angela Elena Vinturache2, Gianfranca Cabiddu3, Rossella Attini4, Loreto Gesualdo1, Elisabetta Versino5, Giorgina Barbara Piccoli6.   

Abstract

Preeclampsia is a pregnancy-related syndrome of variable severity, classically characterized by acute kidney involvement, with hypertension and/or proteinuria and reduced kidney function. Once considered a self-limited disease healed by delivery, it is now acknowledged that preeclampsia can affect cardiovascular and kidney health in the long term. The entity of risk has not been established and consequently follow-up policies have not been defined. Here we undertook a systematic review to gain better insights into the need for post-preeclampsia follow-up. Articles published between January 2000 and March 2018 were selected, dealing with at least 20 preeclampsia patients, with follow-up of 4 years or more (MEDLINE, Embase, and Cochrane Library). No quality selection or language restriction was performed. Of the 10,510 titles and abstracts originally considered, 21 papers were selected, providing information on 110,803 cases with and 2,680,929 controls without preeclampsia, with partial overlap between studies on the same databases. Heterogeneity was high, and a random meta-analytic model selected. The increase in risk of end stage renal disease after preeclampsia was significant (meta-analytic risk ratios (95% confidence interval) 6.35 (2.73-14.79)); the risk of albuminuria and chronic kidney disease increased but statistical significance was not reached (4.31 (0.95-19.58) and 2.03 (0.58-7.32), respectively). Translating meta-analytic risk into the number of patients who need follow-up to detect one adverse event, 310 patients with preeclampsia are needed to identify one woman with end stage renal disease or four to identify one woman with albuminuria. Heterogeneity in definitions, insufficient follow-up and incomplete recruitment may account for discrepancies. Thus, preeclampsia significantly increases the risk of end stage renal disease. However, there is lack of sufficient data to show a relationship between preeclampsia, albuminuria and chronic kidney disease, underlining the need for further prospective studies.
Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  albuminuria; chronic kidney disease; dialysis; eGFR; hypertensive disorders of pregnancy; preeclampsia; rapid review; systematic review

Year:  2019        PMID: 31352975     DOI: 10.1016/j.kint.2019.03.033

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

1.  Pre-kidney Donation Pregnancy Complications and Long-term Outcomes.

Authors:  Erika S Helgeson; Elise F Palzer; David M Vock; Paige Porrett; Deirdre Sawinski; Arthur J Matas
Journal:  Transplantation       Date:  2022-04-11       Impact factor: 5.385

Review 2.  Pregnancy and cardiovascular disease.

Authors:  Karishma P Ramlakhan; Mark R Johnson; Jolien W Roos-Hesselink
Journal:  Nat Rev Cardiol       Date:  2020-06-09       Impact factor: 32.419

3.  Low-dose aspirin for the prevention of severe preeclampsia in patients with chronic kidney disease: a retrospective study : This is the study for kidney and pregnancy...

Authors:  Menglu Wang; Shi Chen; Yingdong He; Minghui Zhao; Huixia Yang; Qian Chen
Journal:  J Nephrol       Date:  2021-04-29       Impact factor: 3.902

Review 4.  Sex and gender: modifiers of health, disease, and medicine.

Authors:  Franck Mauvais-Jarvis; Noel Bairey Merz; Peter J Barnes; Roberta D Brinton; Juan-Jesus Carrero; Dawn L DeMeo; Geert J De Vries; C Neill Epperson; Ramaswamy Govindan; Sabra L Klein; Amedeo Lonardo; Pauline M Maki; Louise D McCullough; Vera Regitz-Zagrosek; Judith G Regensteiner; Joshua B Rubin; Kathryn Sandberg; Ayako Suzuki
Journal:  Lancet       Date:  2020-08-22       Impact factor: 79.321

5.  Chronic kidney disease and pregnancy outcomes.

Authors:  Jan Dvořák; Michal Koucký; Eva Jančová; Marek Mysliveček; Vladimír Tesař; Antonín Pařízek
Journal:  Sci Rep       Date:  2021-10-29       Impact factor: 4.379

6.  Postnatal assessment for renal dysfunction in women with hypertensive disorders of pregnancy : A prospective observational study.

Authors:  Emmanouil Kountouris; Katherine Clark; Polly Kay; Nadia Roberts; Kate Bramham; Nikos A Kametas
Journal:  J Nephrol       Date:  2021-09-24       Impact factor: 3.902

7.  History of Preeclampsia in Patients Undergoing a Kidney Biopsy: A Biphasic, Multiple-Hit Pathogenic Hypothesis.

Authors:  Gianfranca Cabiddu; Elisa Longhitano; Emanuela Cataldo; Nicola Lepori; Antoine Chatrenet; Massimo Torreggiani; Rossella Attini; Bianca Masturzo; Michele Rossini; Elisabetta Versino; Gabriella Moroni; Antonello Pani; Loreto Gesualdo; Domenico Santoro; Giorgina Barbara Piccoli
Journal:  Kidney Int Rep       Date:  2021-12-17

Review 8.  Vitamin D Levels in Early and Middle Pregnancy and Preeclampsia, a Systematic Review and Meta-Analysis.

Authors:  Kai-Lun Hu; Chun-Xi Zhang; Panpan Chen; Dan Zhang; Sarah Hunt
Journal:  Nutrients       Date:  2022-02-27       Impact factor: 5.717

9.  Empagliflozin Ameliorates Preeclampsia and Reduces Postpartum Susceptibility to Adriamycin in a Mouse Model Induced by Angiotensin Receptor Agonistic Autoantibodies.

Authors:  Ruonan Zhai; Yuan Liu; Jiahao Tong; Ying Yu; Lin Yang; Yong Gu; Jianying Niu
Journal:  Front Pharmacol       Date:  2022-03-23       Impact factor: 5.810

Review 10.  The Changing Landscape of Acute Kidney Injury in Pregnancy from an Obstetrics Perspective.

Authors:  Angela Vinturache; Joyce Popoola; Ingrid Watt-Coote
Journal:  J Clin Med       Date:  2019-09-06       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.